Tech Company Financing Transactions

Emulate Funding Round

Emulate, based in Boston, secured $12 million from Cedars-Sinai Medical Center, NanoDimension and private investors.

Transaction Overview

Company Name
Emulate
Announced On
7/29/2014
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors

Cedars-Sinai Medical Center (Lead Investor) (Shlomo Melmed)

NanoDimension (Lead Investor)

private investors (Hansjörg Wyss)

Proceeds Purpose
Emulate will use the proceeds from the financing to advance the first commercial applications of its automated Organs-on-Chips platform through co-innovation with corporate and clinical clients, and through internal development programs.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
27 Drydock Ave.
Boston, MA 02210
USA
Phone
(508) 843-5324
Website
www.emulatebio.com
Email Address
[email protected]
Overview
Official website of Emulate, Inc. Based on our Organs-on-Chips technology, we have created a new living system that emulates human biology.
Profile
Emulate LinkedIn Company Profile
Social Media
Emulate Company Twitter Account
Company News
Emulate News
Facebook
Emulate on Facebook
YouTube
Emulate on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Corbett
  James Corbett LinkedIn Profile  James Corbett Twitter Account  James Corbett News  James Corbett on Facebook
Chief Financial Officer
Scott Kantor
  Scott Kantor LinkedIn Profile  Scott Kantor Twitter Account  Scott Kantor News  Scott Kantor on Facebook
Chief Scientific Officer
Lorna Ewart
  Lorna Ewart LinkedIn Profile  Lorna Ewart Twitter Account  Lorna Ewart News  Lorna Ewart on Facebook
Chief Technical Officer
Daniel Levner
  Daniel Levner LinkedIn Profile  Daniel Levner Twitter Account  Daniel Levner News  Daniel Levner on Facebook
Founder
Donald Ingber
  Donald Ingber LinkedIn Profile  Donald Ingber Twitter Account  Donald Ingber News  Donald Ingber on Facebook
Vice President
Chris Hinojosa
  Chris Hinojosa LinkedIn Profile  Chris Hinojosa Twitter Account  Chris Hinojosa News  Chris Hinojosa on Facebook
Vice President
Kyung Jang
  Kyung Jang LinkedIn Profile  Kyung Jang Twitter Account  Kyung Jang News  Kyung Jang on Facebook
VP - General Counsel
Larry Weiss
  Larry Weiss LinkedIn Profile  Larry Weiss Twitter Account  Larry Weiss News  Larry Weiss on Facebook
VP - Human Resources
Sandy Lazzari
  Sandy Lazzari LinkedIn Profile  Sandy Lazzari Twitter Account  Sandy Lazzari News  Sandy Lazzari on Facebook
VP - Human Resources
Stacy Perro
  Stacy Perro LinkedIn Profile  Stacy Perro Twitter Account  Stacy Perro News  Stacy Perro on Facebook
VP - Marketing
Jenn Perkins
  Jenn Perkins LinkedIn Profile  Jenn Perkins Twitter Account  Jenn Perkins News  Jenn Perkins on Facebook
VP - Product Management
Luke Dimasi
  Luke Dimasi LinkedIn Profile  Luke Dimasi Twitter Account  Luke Dimasi News  Luke Dimasi on Facebook
VP - Regulatory Affairs
Ernie Ansah
  Ernie Ansah LinkedIn Profile  Ernie Ansah Twitter Account  Ernie Ansah News  Ernie Ansah on Facebook
VP - Sales
Stuart Gibb
  Stuart Gibb LinkedIn Profile  Stuart Gibb Twitter Account  Stuart Gibb News  Stuart Gibb on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/29/2014: EyeNetra venture capital transaction
Next: 7/29/2014: SafeOp Surgical venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.